Clinical and Histopathologic Features of Hair Loss in Patients with HIV-1 Infection

    Kathleen J. Smith, Henry G. Skelton, Deanna DeRusso, Leonard C. Sperling, Josef Yeager, Kenneth F. Wagner, Peter Angritt
    Image of study
    TLDR People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.
    In 1996, a study involving 10 patients with late-stage HIV-1 infection found that all experienced telogen effluvium, a form of hair loss where hair prematurely enters the resting phase. Histological analysis showed a significant number of apoptotic or necrotic keratinocytes in the hair follicle's upper external root sheath and a mild to moderate perifollicular mononuclear cell infiltrate with eosinophils. Hair shaft dystrophy was also consistently present. The study concluded that these features, particularly the apoptotic or necrotic keratinocytes and hair dystrophy, might be specific to hair loss in HIV-1 patients. It was noted that hair straightening, particularly in black patients, could contribute to the hair loss, which was not solely related to drug use or nutritional deficiencies. The causes of hair loss in these patients appeared to be multifactorial, potentially including nutritional deficiencies, hormonal imbalances, and autoimmune responses akin to graft-versus-host disease.
    Discuss this study in the Community →

    Research cited in this study

    4 / 4 results

    Related Community Posts Join

    6 / 419 results

      community Sandalore: a scientific homemade approch

       20 upvotes 6 years ago
      The post discusses using Sandalore as a potential hair loss treatment, emphasizing precise measurements and safe handling. The user compares Sandalore's effects to Minoxidil and mentions preparing a solution with ethanol and DMSO.

      community HLT Megathread on HMI-115 (key takeaways in comments)

      in Research/Science  39 upvotes 1 year ago
      HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.

      community My Telogen Effluvium journey after a bad Keratin Treatment

      in Female  6 upvotes 1 year ago
      A user shared their experience with telogen effluvium triggered by a keratin treatment, leading to significant hair loss. They found improvement using aloe vera with rosemary, a protein and iron-rich diet, and patience.

      community Is 2years+ telogen effluvium possible?

      in Finasteride/Dutasteride  2 upvotes 5 months ago
      The user has been losing hair for over two years despite taking dutasteride and RU58841, even increasing dutasteride to 2.5mg. They are questioning if their hair loss could be due to telogen effluvium instead.

    Related Research

    7 / 7 results